Matches in DBpedia 2014 for { <http://dbpedia.org/resource/CryoLife> ?p ?o. }
Showing items 1 to 60 of
60
with 100 items per page.
- CryoLife abstract "CryoLife, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.CryoLife, Inc. incorporated in 1984 in Florida, was the first biomedical company to specialize in the ultra-low temperature preservation of human heart valves used for cardiac reconstruction, primarily in children born with heart defects. The Company preserves and distributes human tissues and develops, manufactures, and commercializes medical devices for cardiac and vascular transplant applications. The human tissues distributed by CryoLife include the CryoValve® SG pulmonary human heart valve and the CryoPatch® SG pulmonary cardiac patch tissue, both processed using CryoLife’s proprietary SynerGraft® technology. CryoLife’s medical devices consist primarily of surgical adhesives, sealants, and hemostats including BioGlue® Surgical Adhesive, BioFoam® Surgical Matrix, PerClot®, which the Company began distributing for Starch Medical, Inc. in October 2010.The Company preserves small diameter human saphenous vein conduits (3mm to 6mm) for use in peripheral vascular reconstructions and coronary bypass surgery. Failure to achieve revascularization of an obstructed vessel may result in the loss of a limb or even death of the patient. When patients require bypass surgery, the surgeon’s first choicegenerally is the patient’s own vein tissue. However, in cases of advanced vascular disease, 30% of patients have unsuitable vein tissue for transplantation, and the surgeon must consider using synthetic grafts or preserved human vascular tissue. Small diameter synthetic vascular grafts are generally not optimal for below-the-knee surgeries because they have a tendency to obstruct over time. Preserved human vascular tissues tend to remain open longer and as such are used in indications where synthetics typically fail. In addition, synthetic grafts are not suitable for use in infected areas since they may harbor bacteria and are difficult to treat with antibiotics. Preserved human vascular tissues are ideal grafts for patients with previously infected graft sites. The Company also preserves femoral veins and arteries and aortoiliac arteries for bypass orreconstruction within infected surgical areas.".
- CryoLife foundingYear "1984".
- CryoLife location Kennesaw,_Georgia.
- CryoLife numberOfEmployees "435".
- CryoLife revenue "1.16E8".
- CryoLife thumbnail CRY-Tag-Logo-Black-White-Background.jpg?width=300.
- CryoLife type Public_company.
- CryoLife wikiPageExternalLink cryovalve.cryolife.com.
- CryoLife wikiPageExternalLink www.caringtoshare.org.
- CryoLife wikiPageExternalLink www.cryolife.com.
- CryoLife wikiPageExternalLink biofoam-surgical-matrix.
- CryoLife wikiPageExternalLink cryovalve-sg-pulmonary-human-heart-valve.
- CryoLife wikiPageExternalLink cryopatch-sg.
- CryoLife wikiPageExternalLink vascular-reconstructive-surgery.
- CryoLife wikiPageExternalLink www.ctsnet.org.
- CryoLife wikiPageExternalLink www.jvascsurg.org.
- CryoLife wikiPageExternalLink www.perclot.com.
- CryoLife wikiPageExternalLink www.theidealsealant.com.
- CryoLife wikiPageExternalLink www.therosscommunity.org.
- CryoLife wikiPageID "24178665".
- CryoLife wikiPageRevisionID "586961661".
- CryoLife foundation "1984".
- CryoLife hasPhotoCollection CryoLife.
- CryoLife location "Kennesaw, Georgia, United States".
- CryoLife logo "200".
- CryoLife name "CryoLife, Inc.".
- CryoLife numEmployees "435".
- CryoLife products "human tissues for transplant, medical devices".
- CryoLife revenue "1.16E8".
- CryoLife type Public_company.
- CryoLife subject Category:Companies_listed_on_the_New_York_Stock_Exchange.
- CryoLife subject Category:Health_care_companies_of_the_United_States.
- CryoLife type Abstraction100002137.
- CryoLife type Company108058098.
- CryoLife type Group100031264.
- CryoLife type HealthCareCompaniesOfTheUnitedStates.
- CryoLife type Institution108053576.
- CryoLife type Organization108008335.
- CryoLife type SocialGroup107950920.
- CryoLife type YagoLegalActor.
- CryoLife type YagoLegalActorGeo.
- CryoLife type YagoPermanentlyLocatedEntity.
- CryoLife type Agent.
- CryoLife type Company.
- CryoLife type Organisation.
- CryoLife type Organization.
- CryoLife type Agent.
- CryoLife type SocialPerson.
- CryoLife type Thing.
- CryoLife comment "CryoLife, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.CryoLife, Inc.".
- CryoLife label "CryoLife".
- CryoLife sameAs m.03p1xln.
- CryoLife sameAs Q5190505.
- CryoLife sameAs Q5190505.
- CryoLife sameAs CryoLife.
- CryoLife wasDerivedFrom CryoLife?oldid=586961661.
- CryoLife depiction CRY-Tag-Logo-Black-White-Background.jpg.
- CryoLife homepage www.cryolife.com.
- CryoLife isPrimaryTopicOf CryoLife.
- CryoLife name "CryoLife, Inc.".
